FDA Reviews Process For Approving Biotech Generics
The Food and Drug Administration is laying the early groundwork for approving generic versions of biotechnology medicines, a policy move riddled with controversy, according to a published report....To view the full article, register now.
Already a subscriber? Click here to view full article